PerspectivePublished 28 January 2026Protein metalation by anticancer metal-based drugs revealed through the integration of ESI-MS and XRD measurements. State of the art and open issuesAntonello Merlino · Tiziano Marzo · Luigi MessoriFrontiers in Chemical Biologydoi 10.3389/fchbi.2026.1758486